Visit our Complete Peptide Injection Guide to learn about recommended injection sites, site rotation, and proper subcutaneous injection technique
The launch of generic liraglutide (Teva, August 2025) and anticipated oral GLP-1 options (oral Wegovy approved December 2025, orforglipron pending) offer lower-cost alternatives that may simplify pharmacy benefit management
A.HickeyM
In addition, our staff is prepared to monitor for, detect, and respond promptly to any potential complications, such as infection, infiltration, or allergic reactions, ensuring you receive the highest standard of care
Clinical Observations: Natural Contouring: Results appear natural, with no abrupt changes, and continue to improve in the weeks following treatment